Incontinentia pigmenti (Bloch-Sulzberger syndrome): A systemic disorder

Cutis

Volumn 79, Issue 5, 2007, Pages 355-362

  Ehrenreich, Michael ^a   Tarlow, Mordechai M ^a   Godlewska Janusz, Elizabeth ^a   Schwartz, Robert A ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; GENETIC PREDISPOSITION; GENETICS; HUMAN; INCONTINENTIA PIGMENTI; PATHOLOGY;

GENETIC PREDISPOSITION TO DISEASE; HUMANS; INCONTINENTIA PIGMENTI;

EID: 34250656239     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (107)

1. Online Mendelian Inheritance in Man, Incontinentia pigmenti. Available at: http://www.ncbi.nlm.nih.gov./entrez/dispomim.cgi?id=308300, Accessed April 17, 2007.
2. Goldberg ME The skin is not the predominant problem in incontinentia pigmenti. Arch Dermatol. 2004;140:748-750.
3. Garrod AE. Peculiar pigmentation of the skin in an infant. Trans Clin Soc London. 1906;39:216.
4. Bloch B. Krunkendemonstrationen aus der Dermatologischen Klinik Zürich. 1. Eigentümliche, bisher nicht beschriebene Pigmentaffektin (Incontinentia pigmenti). Schweitz Med Wochenschr. 1926;56:404-405.
5. Sulzberger MB. Ûber eine bisher nicht beschriebene congenitale Pigmentanomalie (Incontentia pigmenti). Arch Dermatol Syphil. 1928;154:19-32.
6. Sulzberger MB, Fraser JF, Hutner L. Incontinentia pigmenti (Bloch-Sulzburger). report of an additional case, with comment on possible relation to a new syndrome of familial and congenital anomalies. Arch Dermatol Syphil. 1938;38:57-69.
7. Sefiani A, M'rad R, Simard L, et al. Linkage relationship between incontinentia pigmenti (IP2) and nine terminal X long arm markers. Hum Genet. 1991;86:297-299.
8. Sefiani A, Abel L, Heuertz S, et al. The gene for incontinentia pigmenti is assigned to Xq28. Genomics. 1989;4:427-429.
9. Smahi A, Hydén-Granskog C, Peterlin B, et al. The gene for the familial form of incontinentia pigmenti (IP2) maps to the distal part of Xq28. Hum Mol Genet. 1994;3:273-278.
10. Cannizzaro LA, Hecht F. Gene for incontinentia pigmenti maps to band Xp11 with an (X;10) (p11;q22) translocation. Clin Genet. 1987;32:66-69.
11. Happle R. Incontinentia pigmenti versus hypomelanosis of Ito: the whys and wherefores of a confusing issue. Am J Med Genet. 1998;79:64-65.
12. Aradhya S, Woffendin H, Jakins T, et al. A recurrent deletion in the ubiquitously expressed NEMO (IKK-gamma) gene accounts for the vast majority of incontinentia pigmenti mutations. Hum Mol Genet. 2001;10:2171-2179.
13. Fusco F, Bardaro T, Fimiani G, et al. Molecular analysis of the genetic defect in a large cohort of IP patients and identification of novel NEMO mutations interfering with NFkappaB activation. Hum Mol Genet. 2004;13:1763-1773.
14. Hadj-Rabia S, Froidevaux D, Bodak N, et al. Clinical study of 40 cases of incontinentia pigmenti. Arch Dermatol. 2003;139:1163-1170.
15. Kirchman TT, Levy ML, Lewis RA, et al. Gonadal mosaicism for incontinentia pigmenti in a healthy male. J Med Genet. 1995;32:887-890.
16. Smahi A, Courtois G, Vabres P, et al. Genomic rearrangement in NEMO impairs NF-kappaB activation and is a cause of incontinentia pigmenti. The International Incontinentia Pigmenti (IP) Consortium. Nature. 2000;405:466-472.
17. Parrish JE, Scheuerle AE, Lewis RA, et al. Selection against mutant alleles in blood leukocytes is a consistent feature in incontinentia pigmenti type 2. Hum Mol Genet. 1996;5:1777-1783.
18. Harris A, Collins J, Vetrie D. X inactivation as a mechanism of selection against lethal alleles: further investigation of incontinentia pigmenti and X linked lymphoproliferative disease. J Med Genet. 1992;29:608-614.
19. Silan F, Aydogan I, Kavak A, et al. Incontinentia pigmenti with NEMO mutation in a Turkish family. Int J Dermatol. 2004;43:527-529.
20. Carney RG. Incontinentia pigmenti: a world statistical analysis. Arch Dermatol. 1976;112:535-542.
21. Scheuerle AE. Male cases of incontinentia pigmenti: case report and review. Am J Med Genet. 1998;77:201-218.
22. Cho SY, Lee CK, Drummond BK. Surviving male with incontinentia pigmenti: a case report. Int J Paediatr Dent. 2004;14:69-72.
23. Traupe H, Vehring KH. Unstable pre-mutation may explain mosaic disease expression of incontinentia pigmenti in males. Am J Med Genet. 1994;49:397-398.
24. Mayer EJ, Shuttleworth GN, Greenhalgh KL, et al. Novel corneal features in two males with incontinentia pigmenti. Br J Ophthalmol. 2003;87:554-556.
25. Ormerod AD, White MI, McKay E, et al. Incontinentia pigmenti in a boy with Klinefelter's syndrome. J Med Genet. 1987;24:439-441.
26. Prendiville JS, Gorski JL, Stein CK, et al. Incontinentia pigmenti in a male infant with Klinefelter syndrome. J Am Acad Dematol 1989;20(pt 2):937-940.
27. Garcia-Dorado J, de Unamuno P, Fernandez-Lopez E, et al. Incontinentia pigmenti: XXY male with a family history. Clin Genet. 1990;38:128-138.
28. Kenwrick S, Woffendin H, Jakins T, et al. Survival of male patients with incontinentia pigmenti carrying a lethal mutation can be explained by somatic mosaicism or Klinefelter syndrome. Am J Hum Genet. 2001;69:1210-1217.
29. Tanaka K, Kambe N, Fujita M, et al. Incontinentia pigmenti in identical twins with separate skin and neurological disorders. Acta Derm Venereal. 1990;70:267-268.
30. Landy SJ, Donnai D, Incontinentia pigmenti (Bloch-Sulzberger syndrome). J Med Genet. 1993;30:53-59.
31. Jackson R. The lines of Blaschko: a review and reconsideration: observations of the cause of certain unusual linear conditions of the skin. Br J Dermatol 1976;95:349-360.
32. Bodak N, Hadj-Rabia S, Hamel-Teillac D, et al. Late recurrence of inflammatory first-stage lesions in incontinentia pigmenti: an unusual phenomenon and a fascinating pathologic mechanism. Arch Dermatol. 2003;139:201-204.
33. van Leeuwen RL, Wintzen M, van Praag MC. Incontinentia pigmenti: an extensive second episode of a "first-stage" vesicobullous eruption. Pediatr Dermatol. 2000;17:70.
34. Pfau A, Landthaler M. Recurrent inflammation in incontinentia pigmenti of a seven-year-old child. Dermatology. 1995;191:161-163.
35. De Argua D, Rivera R, Guerra A, et al. Incontinentia pigmenti: a case with an unusual course. Pediatr Dematol. 1996;13:434-435.
36. Dutheil P, Vabres P, Cayla MC, et al. Incontinente pigmenti: late sequelae and genotypic diagnosis: a three-generation study of four patients. Pediatr Dermatol. 1995;12:107-111.
37. Nazzaro V, Brusasco A, Gelmetti C, et al. Hypochromic reticulated streaks in incontinentia pigmenti: an immunohistochemical and ultrastructural study. Pediatr Dermatol. 1990;7:174-178.
38. Chan YC, Happle R, Giam YC. Whorled scarring alopecia: a rare phenomenon in incontinentia pigmenti? J Am Acad Dematol. 2003;49:929-931.
39. Nicolaou N, Graham-Brown RA, Nail dystrophy, an unusual presentation of incontinentia pigmenti, Br J Dermatol. 2003;149:1286-1288.
40. Hartman DL. Incontinentia pigmenti associated with subungual tumors. Arch Dermatol. 1966;94:632-635.
41. Montes CM, Maize JC, Guerry-Force ML. Incontinentia pigmenti with painful subungual tumors: a two-generation study. J Am Acad Dermotol. 2004;50(suppl 2): S45-S52.
42. Adeniran A, Townsend A, Peachey RD. Incontinentia pigmenti manifesting as painful and subungual tumours. J Hand Surg. 1993;18:667-669.
43. Mascaró JM, Palou J, Vives P. Painful subungual keratotic tumours in incontinentia pigmenti. J Am Acad Dermatol. 1985;13:913-918.
44. Simmons DA, Kegel MF, Scher RK, et al. Subungual tumours in incontinentia pigmenti. Arch Dermatol. 1986;122:1431-1434.
45. Abimelec P, Rybojad M, Cambiaghi S, et al. Late, painful, subungual hyperkeratosis in incontinentia pigmenti. Pediatr Dermatol 1995;12:340-342.
46. Holmström G, Thorén K. Ocular manifestations of incontinentia pigmenti. Acta Ophthalmol Scand. 2000;78:348-353.
47. Jandeck C, Kellner U, Foerster MH. Successful treatment of severe retinal vascular abnormalities in incontinentia pigmenti. Retina. 2004;24:631-633.
48. Goldberg MF. Macular vasculopathy and its evolution in incontinentia pigmenti. Ophthalmic Genet. 1998;19:141-148.
49. Shaikh S, Trese MT, Archer SM. Fluorescein angiographic findings in incontinentia pigmenti. Retina. 2004;24:628-629.
50. Meallet MA, Song J, Stout JT. An extreme case of retinal avascularity in a female neonate with incontinentia pigmenti. Retina. 2004;24:613-615.
51. Wong GA, Willoughby CE, Parslew R, et al. The importance of screening for sight-threatening retinopathy in incontinentia pigmenti. Pediatr Dermatol. 2004;21:242-245.
52. Shah GK, Summers CG, Walsh AW, et al. Optic nerve neovascularization in incontinentia pigmenti. Am J ophthalmol. 1997;124:410-412.
53. Ferreira RC, Ferreira LC, Forstot L, et al. Corneal abnormalities associated with incontinentia pigmenti. Am J Ophthalmol. 1997;123:549-551.
54. Goldberg MF, Custis PH. Retinal and other manifestations of incontinentia pigmenti (Bloch-Sulzberger syndrome). Ophthalmology. 1993;100:1645-1654.
55. Goldberg MF. The blinding mechanisms of incontinentia pigmenti. Ophthalmic Genet. 1994;15:69-76.
56. Shah SN, Gibbs S, Upton CJ, et al. Incontinentia pigmenti associated with cerebral palsy and cerebral leukomalacia: a case report and literature review. Pediatr Dermatol. 2003;20:491-494.
57. Pellegrino RJ, Shah AJ. Vascular occlusion associated with incontinentia pigmenti. Pediatr Neural. 1994;10:73-74.
58. Hennel SJ, Ekert PG, Volpe JJ, et al. Insights into the pathogenesis of cerebral lesions in incontinentia pigmenti. Pediatr Neurol. 2003;29:148-150.
59. Fiorillo L, Sinclair DB, O'Byrne ML, et al. Bilateral cerebrovascular accidents in incontinentia pigmenti. Pediatr Neurol. 2003;29:66-68.
60. Aydingoz U, Midia M. Central nervous system involvement in incontinentia pigmenti: cranial MRI of two siblings. Neuroradiology. 1998;40:364-366.
61. Shuper A, Bryan RN, Singer H. Destructive encephalopathy in incontinentia pigmenti: a primary disorder? Pediatr Neural. 1990;6:137-140.
62. Porksen G, Pfeiffer C, Hahn G, et al. Neonatal seizures in two sisters with incontinentia pigmenti. Neuropediatrics. 2004;35:139-142.
63. Hubert JN, Gallen JP. Incontinentia pigmenti presenting as seizures. Pediatr Dermatol. 2002;19:550-552.
64. Yang JH, Ma SY, Tsai CH. Destructive encephalopathy in incontinentia pigmenti: a case report. J Dermatol. 1995;22:340-343.
65. Senturk N, Aydin F, Haciomeroglu P, et al. Pulmonary tuberculosis and cutaneous mycobacterial infection in a patient with incontinentia pigmenti. Pediatr Dermatol, 2004;21:660-663.
66. Aradhya S, Courtois G, Rajkovic A, et al. Atypical forms of incontinentia pigmenti in male individuals result from mutations of a cytosine tract in exon 10 of NEMO (IKKgamma). Am J Hum Genet. 2001;68:765-771.
67. Menni S, Piccinno R, Biolchini A, et al. Immunologic investigations in eight patients with incontinentia pigmenti. Pediatr Dermatol. 1990;7:275-277.
68. Godambe S, McNamara P, Rajguru M, et al. Unusual neonatal presentation of incontinentia pigmenti with persistent pulmonary hypertension of the newborn: a case report. J Perinatol. 2005;25:289-292.
69. Hayes IM, Varigos G, Upjohn EJ, et al. Unilateral acheiria and fatal primary pulmonary hypertension in a girl with incontinentia pigmenti. Am J Med Genet. 2005;135:302-303.
70. Miteva L, Nikolova A. Incontinentia pigmenti: a case associated with cardiovascular anomalies. Pediatr Dermatol. 2001;18:54-56.
71. Urban J, Toruniowa B, Janniger CK, et al. Incontinentia pigmenti (Bloch-Sulzberger syndrome): multisystem disease observed in two generations. Cutis. 1996;58:329-336.
72. Wood AE, Boyle D, O'Hara MD, et al. Mitral annuloplasty in endomyocardial fibrosis: an alternative to valve replacement. Ann Thorac Surg. 1982;34:446-451.
73. Yell JA, Walshe M, Desai SN. Incontinentia pigmenti associated with bilateral cleft lip and palate. Clin Exp Dermatol 1991;16:49-50.
74. Schnur RE. Genodermatoses 2003-2004. Curr Opin Pediatr. 2004;16:678-688.
75. Courtois G. The NF-kappaB signaling pathway in human genetic diseases. Cell Mol Life Sci. 2005;62:1682-1691.
76. Gilmore TD. Rel/NF- B signal transduction pathway. Available at: http://people.bu.edu/gilmore/nf-kb/. Accessed April 17, 2007.
77. Doffinger RA, Smahi A, Bessia C, et al. X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappaB signaling. Nat Genet. 2001;27:277-285.
78. Zonana J, Elder ME, Schneider LC, et al. A novel X-linked disorder of immune deficiency and hypohidrocic ectodermal dysplasia is allelic to incontinentia pigmenti and due to mutations in IKK-gamma. Am J Hum Genet. 2000;67:1555-1562.
79. Smahi A, Courtois G, Rabia SH, et al, The NF-kappaB signaling pathway in human diseases: from incontinentia pigmenti to ectodermal dysplasias and immunedeficiency syndromes. Hum Mol Genet. 2002;11:2371-2375.
80. Mansour S, Woffendin H, Mitton S, et al. Incontinentia pigmenti in a surviving male is accompanied by hypohidrotic ectodermal dysplasia and recurrent infection. Am J Med Genet. 2001;99:172-177.
81. Dupuis-Girod S, Corradini N, Hadj-Rabia S, et al. Osteopetrosis, lymphedema, anhidrotic ectodermal dysplasia, and immunodeficiency in a boy and incontinentia pigmenti in his mother. Pediatrics. 2002;109:e97.
82. Schmidt-Supprian M, Bloch W, Courtois G, et al. NEMO/IKK gamma-deficient mice model incontinentia pigmenti. Mol Cell. 2000;5:981-992.
83. Makris C, Godfrey VL, Krahn-Senftleben G, et al. Female mice heterozygous for IKK gamma/NEMO deficiencies develop a dermatopathy similar to the human X-linked disorder incontinentia pigmenti. Mol Cell. 2000;5:969-979.
84. Wieacker P, Zimmer J, Ropers HH. X inactivation patterns in two syndromes with probable X-linked dominant, male lethal inheritance. Clin Genet. 1985;28:238-242.
85. Migeon BR, Axelman J, Jan de Beur S, et al. Selection against lethal alleles in females heterozygous for incontinentia pigmenti. Am J Hum Genet. 1989;44;100-106.
86. Machado-Pinto J, McCalmont TH, Golitz LE. Eosinophilic and neutrophilic spongiosis: clues to the diagnosis of immunobullous diseases and other inflammatory disorders. Semin Cutan Med Surg. 1996;15:308-316.
87. Jean-Baptiste S, O'Toole EA, Chen M, et al. Expression of eotaxin, an eosinophil-selective chemokine, parallels eosinophil accumulation in the vesiculobullous stage of incontinentia pigmenti. Clin Exp Immunol. 2002;127:470-478.
88. Thyresson NH, Goldberg NC, Tye MJ, et al. Localization of eosinophil granule major basic protein in incontinentia pigmenti. Pediatr Dematol. 1991;8:102-106.
89. Delaporte E, Janin A, Blondel V, et al. Linear and whorled nevoid hypermelanosis versus incontinentia pigmenti: is pigmentary incontinence really a distinctive feature? Dermatology. 1996;192:70-72.
90. Bardaro T, Falco G, Sparago A, et al. Two cases of misinterpretation of molecular results in incontinentia pigmenti, and a PCR-based method to discriminate NEMO/IKKgamma dene deletion. Hum Mutat. 2003;21:8-11.
91. Stavrianeas NG, Kakepis ME. Incontinentia pigmenti. Orphanet Encyclopedia. Available at: http://www.orpha.net/data/patho/GB/uk- incontinentia-pigmenti.pdf. Accessed April 17, 2007.
92. Faloyin M, Levitt J, Bercowitz E, et al. All that is vesicular is not herpes: incontinentia pigmenti masquerading as herpes simplex virus in a newborn. Pediatrics. 2004;114:270-272.
93. Stitt WZ, Scott GA, Caserta M, et al. Coexistence of incontinentia pigmenti and neonatal herpes simplex virus infection. Pediatr Dermatol. 1998;15:112-115.
94. Fromer ES, Lynch PJ. Neonatal herpes simplex and incontinentia pigmenti. Pediatr Dermatol. 2001;18:86-87.
95. Ciarallo L, Palier AS. Two cases of incontinentia pigmenti simulating child abuse. Pediatrics. 1997;100:E6.
96. Online Mendelian Inheritance in Man. Ectoderemal dysplasia, hypohidrotic, with immune deficiency. Available at: http://www.ncbi.nlm.nih.gov/entrez/ dispomim.cgi?id=300291. Accessed April 17, 2007.
97. Pearlman J, Griego RD, Levy ML, et al. An unusual presentation of incontinentia pigmenti in a 4-month-old girl. Pediatr Dermatol. 1996;13:47-50.
98. Woffendin H, Jakins T, Jouet M, et al. X-inactivation and marker studies in three families with incontinentia pigmenti: implications for counselling and gene localisation. Clin Genet. 1999;55:55-60.
99. Steffann J, Raclin V, Smahi A, et al. A novel PCR approach for prenatal detection of the common NEMO rearrangement in incontinentia pigmenti. Prenat Diagn. 2004;24:384-388.
100. Gigarel N, Frydman N, Burlet P, et al. Single cell co-amplification of polymorphic markers for the indirect preimplamation genetic diagnosis of hemophilia A, X-linked adrenoleukodystrophy, X-linked hydrocephalus and incontinentia pigmenti loci on Xq28. Hum Genet. 2004;114:298-305.
101. Vormittag W, Ensinger C, Raff M, Cytogenetic and dermatoglyphic findings in a familial case of hypomelanosis of Ito (incontinentia pigmenti achromians). Clin Genet. 1992;41:309-314.
102. Wald KJ, Mehta MC, Katsumi O, et al. Retinal detachments in incontinentia pigmenti. Arch Ophthalmol. 1993;111:614-617.
103. Nguyen JK, Brady-Mccreery KM. Laser photocoagulation in preproliferative retinopathy of incontinentia pigmenti. J AAPOS. 2001;5:258-259.
104. Cates CA, Dandekar SS, Flanagan DW, et al. Retinopathy of incontinentia pigmenti: a case report with thirteen years follow-up. Ophthalmic Genet. 2003;24:247-252.
105. Rahi J, Hungerford J. Early diagnosis of the retinopathy of incontinentia pigmenti: successful treatment by cryotherapy. Br J Ophthalmol. 1990;74:377-379.
106. Lee AG, Goldberg MF, Gillard JH, et al. Intracranial assessment of incontinentia pigmenti using magnetic resonance imaging, angiography, and spectroscopic imaging. Arch Pediatr Adolesc Med. 1995;149:573-580.
107. Malvehy J, Palou J, Mascaró JM. Painful subungual tumour in incontinentia pigmenti. response to treatment withetretinate. Br J Dermatol. 1998;138:554-555.